Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Details for Australian Patent Application No. 2006265108 (hide)

Owner Medarex, Inc.

Inventors Wang, Changyu; Passmore, David B.; Srinivasan, Mohan; Korman, Alan J.; Chen, Haibin; Selby, Mark J.; Huang, Haichun

Agent Davies Collison Cave

Pub. Number AU-B-2006265108

PCT Pub. Number WO2007/005874

Priority 60/696,426 01.07.05 US

Filing date 30 June 2006

Wipo publication date 11 January 2007

Acceptance publication date 17 May 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/005874 Priority application(s): WO2007/005874

17 May 2012 Application Accepted

  Published as AU-B-2006265108

20 September 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Aug 2012 . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265113-Compositions and methods for the treatment or prevention of disorders relating to oxidative stress

2006265096-Semiconductor device having a semiconductor-on-insulator (SOI) configuration and including a superlattice on a thin semiconductor layer and associated methods